MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.970
-0.140 (-3.41%)
Sep 10, 2026, 12:17 PM EDT - Market open
MacroGenics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 175.14 | 149.5 | 149.96 | 58.75 | 151.94 | 77.45 | |
Revenue Growth | 21.65% | -0.31% | 155.26% | -61.33% | 96.19% | -26.16% |
Cost of Revenue | 176.45 | 183.18 | 189.49 | 174.81 | 214.41 | 217.23 |
Gross Profit | -1.3 | -33.68 | -39.53 | -116.06 | -62.47 | -139.78 |
Selling, General & Admin | 36.75 | 39.16 | 71.05 | 52.19 | 58.95 | 63.01 |
Operating Expenses | 36.75 | 39.16 | 71.05 | 52.19 | 58.95 | 63.01 |
Operating Income | -38.06 | -72.84 | -110.58 | -168.24 | -121.42 | -202.8 |
Interest Expense | -16.9 | -8.51 | -1.12 | -1.43 | - | - |
Interest & Investment Income | 5.89 | 6.06 | 9.42 | 9.69 | 1.66 | 0.68 |
Other Non Operating Income (Expenses) | - | - | - | 150.93 | - | - |
EBT Excluding Unusual Items | -49.07 | -75.29 | -102.27 | -9.06 | -119.76 | -202.12 |
Gain (Loss) on Sale of Assets | - | - | 36.25 | - | - | - |
Pretax Income | -101.83 | -75.29 | -66.02 | -9.06 | -119.76 | -202.12 |
Income Tax Expense | -0.78 | -0.67 | 0.94 | - | - | - |
Net Income | -14.59 | -74.62 | -66.97 | -9.06 | -119.76 | -202.12 |
Net Income to Common | -14.59 | -74.62 | -66.97 | -9.06 | -119.76 | -202.12 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 63 | 63 | 63 | 62 | 61 | 60 |
Shares Outstanding (Diluted) | 63 | 63 | 63 | 62 | 61 | 60 |
Shares Change | 0.77% | 0.85% | 1.12% | 0.81% | 2.48% | 14.31% |
EPS (Basic) | -0.23 | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 |
EPS (Diluted) | -0.23 | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -65.54 | -82.95 | -72.08 | -79.97 | -90.58 | -150.03 |
Free Cash Flow Per Share | -1.03 | -1.31 | -1.15 | -1.29 | -1.47 | -2.50 |
Gross Margin | -0.74% | -22.53% | -26.36% | -197.54% | -41.11% | -180.49% |
Operating Margin | -21.73% | -48.72% | -73.74% | -286.38% | -79.91% | -261.85% |
Profit Margin | -8.33% | -49.91% | -44.66% | -15.42% | -78.82% | -260.97% |
Free Cash Flow Margin | -37.42% | -55.49% | -48.07% | -136.12% | -59.62% | -193.72% |
EBITDA | -32.17 | -65.67 | -103.04 | -158.6 | -109.55 | -191.54 |
EBITDA Margin | -18.37% | -43.93% | -68.71% | -269.96% | -72.10% | -247.31% |
D&A For EBITDA | 5.89 | 7.17 | 7.54 | 9.65 | 11.87 | 11.26 |
EBIT | -38.06 | -72.84 | -110.58 | -168.24 | -121.42 | -202.8 |
EBIT Margin | -21.73% | -48.72% | -73.74% | -286.38% | -79.91% | -261.85% |
Revenue as Reported | 175.14 | 149.5 | 149.96 | 58.75 | 151.94 | 77.45 |